E-LIB Suche - Ergebnisse für: Liu, Joyce F.

1

Phase I/II Study of Combined BCL-xL and MEK Inhibition with..:

Corcoran, Ryan B. ; Do, Khanh T. ; Kim, Jeong E....
Clinical Cancer Research. 30 (2024) 9 - p. 1739-1749 , 2024

Link: https://doi.org/10.1158/..

2

A phase 2 trial exploring the significance of homologous re..:

Liu, Joyce F. ; Xiong, Niya ; Wenham, Robert M....
Gynecologic Oncology. 187 (2024) - p. 105-112 , 2024

Link: https://doi.org/10.1016/..

3

Combined aromatase, CDK4/6 and PI3K blockade using letrozol..:

Konstantinopoulos, Panagiotis A. ; Xiong, Niya ; Krasner, Carolyn...
Gynecologic Oncology Reports. 52 (2024) - p. 101348 , 2024

Link: https://doi.org/10.1016/..

4

Feasibility and acceptability of a nurse-led telehealth int..:

Pozzar, Rachel A. ; Enzinger, Andrea C. ; Howard, Catherine...
Gynecologic Oncology. 188 (2024) - p. 1-7 , 2024

Link: https://doi.org/10.1016/..

5

STING agonism overcomes STAT3-mediated immunosuppression an..:

Ding, Liya ; Wang, Qiwei ; Martincuks, Antons...
Journal for ImmunoTherapy of Cancer. 11 (2023) 1 - p. e005627 , 2023

Link: https://doi.org/10.1136/..

6

Pilot randomized trial of an acceptance-based telehealth in..:

Wright, Alexi A. ; Poort, Hanneke ; Tavormina, Anna...
Gynecologic Oncology. 177 (2023) - p. 165-172 , 2023

Link: https://doi.org/10.1016/..

7

Rational Combinations of PARP Inhibitors with HRD-Inducing ..:

, In: Targeting the DNA Damage Response for Cancer Therapy; Cancer Treatment and Research,

Lee, Elizabeth K. ; Liu, Joyce F. - p. 171-188 , 2023

Link: https://doi.org/10.1007/..

8

One fixed dosing of a poly(adenosine diphosphate ribose) po..:

Lee, Jung‐Min ; Liu, Joyce F.
Cancer. 129 (2023) 12 - p. 1795-1796 , 2023

Link: https://doi.org/10.1002/..

9

Cediranib in Combination with Olaparib in Patients without ..:

Lee, Jung-Min ; Moore, Richard G. ; Ghamande, Sharad...
Clinical Cancer Research. 28 (2022) 19 - p. 4186-4193 , 2022

Link: https://doi.org/10.1158/..

10

Improved T-cell Immunity Following Neoadjuvant Chemotherapy..:

Liu, Min ; Tayob, Nabihah ; Penter, Livius...
Clinical Cancer Research. 28 (2022) 15 - p. 3356-3366 , 2022

Link: https://doi.org/10.1158/..

11

Praluzatamab Ravtansine, a CD166-Targeting Antibody–Drug Co..:

Boni, Valentina ; Fidler, Mary J. ; Arkenau, Hendrik-Tobias...
Clinical Cancer Research. 28 (2022) 10 - p. 2020-2029 , 2022

Link: https://doi.org/10.1158/..

12

A phase II study of MK-2206, an AKT inhibitor, in uterine s..:

Stover, Elizabeth H. ; Xiong, Niya ; Myers, Andrea P....
Gynecologic Oncology Reports. 40 (2022) - p. 100974 , 2022

Link: https://doi.org/10.1016/..

13

Satellite repeat RNA expression in epithelial ovarian cance..:

Porter, Rebecca L. ; Sun, Siyu ; Flores, Micayla N....
Journal of Clinical Investigation. 132 (2022) 16 - p. , 2022

Link: https://doi.org/10.1172/..

14

Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Check..:

Lynch, Katherine N. ; Liu, Joyce F. ; Kesten, Nikolas...
Cancers. 13 (2021) 9 - p. 2195 , 2021

Link: https://doi.org/10.3390/..

15

Rationale for combination PARP inhibitor and antiangiogenic..:

Alvarez Secord, Angeles ; O'Malley, David M. ; Sood, Anil K...
Gynecologic Oncology. 162 (2021) 2 - p. 482-495 , 2021

Link: https://doi.org/10.1016/..